&#226;€‹Biopharmaceutical company.
Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products; Consolidated Appropriations Act, 2023 (PL 117-328). Issues related to cannabis research; S. 253 Cannabidiol and Marihuana Research Expansion Act; issues related to the FDA; issues related to Cannabis research at Health and Human Services. Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO